Home drug
 

Keywords :   


Tag: drug

ASCO Report Card: Grading Biotech and Cancer Drug Stocks

2015-06-01 16:19:45| Logistics - Topix.net

I spent a long weekend in chilly, rainy Chicago listening to endless cancer-drug data presentations at the American Society of Clinical Oncology annual meeting. Here are my flash impressions on the biotech and drug companies at this huge cancer conference, and whether they come out looking stronger or weaker.

Tags: report card drug cancer

 

Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz

2015-06-01 14:09:24| Biotech - Topix.net

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.

Tags: good drug cancer breast

 
 

Bristol's Melanoma Drug Combo Is A Cancer Breakthrough. Who Will Get It And Who Won't?

2015-05-31 15:28:09| Biotech - Topix.net

A new cancer treatment from Bristol-Myers Squibb saved Gary McLaughlin's life, but it also landed him in the hospital. Mclaughlin, 75, developed melanoma, the deadly skin cancer, just as he was retiring for real.

Tags: it who drug cancer

 

Allegiant Air could pay $266K fine for lapses in drug testing FAA says

2015-05-31 08:20:13| Airlines - Topix.net

Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news. With a traditional newspaper format, more than 100 sites were established each with a newspaper-type name to cover the highest-ranked regions, countries, cities and states.

Tags: air pay fine says

 

Pfizer's Ibrance drug slows progression of breast cancer

2015-05-30 19:03:57| Biotech - Topix.net

CHICAGO: A Phase III trial of Pfizer Inc's drug Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer. At the time of an interim analysis, patients given Ibrance in combination with AstraZeneca Plc's Faslodex , a widely used treatment to block estrogen, lived an average of 9.2 months before their cancer worsened.

Tags: drug cancer breast progression

 

Sites : [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] next »